14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £5.34 £19.02 Tuesday, 7th May 2024 OXB.L stock ended at £328.00. During the day the stock fluctuated 0% from a day low at £328.00 to a day high of £328.00.
90 days £17.30 £19.02
52 weeks £16.32 £20.85

Historical Oxford Biomedica prices

Date Open High Low Close Volume
May 07, 2024 £328.00 £328.00 £328.00 £328.00 0
May 03, 2024 £304.00 £350.00 £301.53 £328.00 1 213 153
May 02, 2024 £286.74 £304.77 £280.50 £300.00 360 811
May 01, 2024 £280.00 £289.00 £268.50 £287.00 495 431
Apr 30, 2024 £260.00 £289.84 £250.50 £276.50 627 154
Apr 29, 2024 £224.00 £262.94 £220.52 £260.00 641 647
Apr 26, 2024 £213.95 £234.00 £213.95 £228.50 269 131
Apr 25, 2024 £219.00 £223.00 £212.50 £220.00 157 766
Apr 24, 2024 £218.00 £225.00 £211.50 £218.50 276 061
Apr 23, 2024 £215.50 £220.00 £211.50 £215.00 988 842
Apr 22, 2024 £206.00 £216.50 £203.20 £212.50 590 476
Apr 19, 2024 £202.00 £208.00 £200.00 £203.00 187 792
Apr 18, 2024 £196.00 £205.00 £190.00 £205.00 148 760
Apr 17, 2024 £197.00 £197.00 £187.83 £190.40 375 430
Apr 16, 2024 £204.00 £204.00 £193.00 £195.20 178 287
Apr 15, 2024 £202.00 £202.84 £195.80 £202.00 90 359
Apr 12, 2024 £203.00 £209.67 £198.00 £202.50 150 474
Apr 11, 2024 £197.53 £209.50 £197.53 £209.50 92 591
Apr 10, 2024 £196.00 £207.63 £196.00 £202.50 135 376
Apr 09, 2024 £201.50 £203.81 £198.13 £203.00 185 650
Apr 08, 2024 £201.60 £206.50 £201.00 £201.00 372 601
Apr 05, 2024 £199.80 £203.50 £197.23 £203.50 55 261
Apr 04, 2024 £201.50 £205.00 £197.00 £203.00 145 138
Apr 03, 2024 £203.00 £203.00 £190.20 £199.00 236 168
Apr 02, 2024 £201.00 £201.00 £201.00 £201.00 0
Click to get the best stock tips daily for free!

About Oxford Biomedica

Oxford Biomedica Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. The company operates in two segments, Platform and Product. Its LentiVector platform technology integrates genes into non-dividing cells, including neurons in the brain and retinal cells in the eye, as well as accommodates various therapeutic genes. The company's products under... OXB.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT